LjLacto Lactobacillus plantarum LJ Pharma 6 Vaginal Capsules

LjLacto Lactobacillus plantarum LJ Pharma - Medical Device

Vaginal use

ACTIVE PRINCIPLES

Each vaginal capsule contains: Active ingredient: Lactobacillus plantarum P 17630 at least 108 UFC For the full list of excipients, see section 6.1

EXCEPTIONS

Each vaginal capsule contains: Ethyl p-oxybenzoate sodium - Propyl p-oxybenzoate sodium - Medium chain triglycerides - Silica (Aerosil 300) - Gelatin - Glycerol - Dimethylpolysiloxane - Titanium dioxide (E 171) - Lactose - Cryoprotectant (Low-fat milk powder - Sucrose - Sorbitol - Sodium ascorbate - Tween 80).

THERAPEUTIC INDICATIONS

LJLACTO soft vaginal capsules are indicated in "vaginitis and vulvo-vaginitis" in general, as the lactobacilli present in them, implanting and multiplying on the vaginal mucosa, in addition to restoring the balance of the autochthonous bacterial flora, indirectly antagonize the colonization by pathogenic germs. LJLACTO is therefore used, starting from the fertile age, in the topical therapy of vaginal infections caused by pathogenic germs. In particular in vaginitis associated with ovarian insufficiency, hypofollicolinic leukorrhea, senile vaginitis, vulvar pruritus, vaginal dystrophy. LJLACTO is also used as an adjuvant in the chemotherapy and antibiotic treatment in Trichomonas vaginitis.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients

DOSAGE

One vaginal capsule per day. How to use: Introduce a capsule deeply into the vagina, in the supine position, in the evening before bedtime.

STORAGE

Store the medicine at a temperature between + 2 ° C and + 8 ° C.

WARNINGS

The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena and produce undesirable effects. In this case it is necessary to stop the treatment and consult your doctor. LJLACTO does not replace antibiotic or chemotherapy therapy, but represents a useful complement by restoring, especially at the end of the specific treatment, the physiological conditions of the vaginal environment. Keep this medicine out of the reach and sight of children

INTERACTION

No interaction studies have been performed.

SIDE EFFECTS

No undesirable effects related to the use of the medicine have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

OVERDOSE

No cases of overdose have been reported.

PREGNANCY - NURSING

Lactobacillus plantarum is a habitual non-pathogenic host of the vagina, therefore LJLACTO can be used during pregnancy and / or during breastfeeding.

Format

Pack with 6 soft capsules.